A Double-Blind, Randomized, Dose-finding Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis
Phase of Trial: Phase II
Latest Information Update: 19 Aug 2014
Price : $35 *
At a glance
- Drugs Tegoprazan (Primary) ; Esomeprazole
- Indications Erosive oesophagitis
- Focus Therapeutic Use
- Sponsors CJ Cheiljedang Corp.
- 07 Aug 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jan 2014 New trial record